PRL and neoplasm: In DA resistant patients from which both data on tumor shrinkage and PRL levels were available (n = 18), DA treatment resulted in normalization of PRL levels in 7 (39%), despite a lack of tumor shrinkage by more than 30% (supplementary Table 1).